Kasper S
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Center for Brain Research, Department of Molecular Neuroscience, Medical University of Vienna, Vienna, Austria.
ArticleAyahuasca
Emerging pharmacological and neuromodulation interventions for suicidal ideation and behaviour.
ArticleKetamine
Real-world effectiveness and safety of intranasal esketamine for treatment-resistant depression: Data from the enTRD registry.
ArticleKetamine
Pharmacological augmentation in treatment-resistant depression: a neurobiologically informed, practical decision guide for treatment choice with lithium, quetiapine, or esketamine.
ArticleKetamine
Beyond first-line antidepressants: lithium, quetiapine, or esketamine? Integrating meta-analyses and preliminary head-to-head evidence.
ArticleKetamine
Human <i>in vivo</i> assessment of ketamine binding of the serotonin transporter-follow up at a higher dose.
ArticleKetamine
Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy.
ArticleKetamine
Overcoming the myths of esketamine administration: different and not difficult.
ArticleKetamine